Part 1: EASL Digital International Liver Congress 2020

ARE YOU A PATIENT LIVING WITH NAFLD/NASH OR HEALTHCARE PROFESSIONAL CARING FOR NAFLD/NASH PATIENTS?

 

Welcome to Fatty Liver Foundation’s LIVER (Live Interactive Virtual Education and Review) Webinar Series. This four-part webinar series will deliver the latest research and medical information, including lifestyle/diet, testing and treatment, to people living with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their medical providers. Our goal is to keep the patient community up-to-date on medical research and to build an archive of the important historical evolution of the field.

 

Join us for part-one of this webinar series on Sep 2, 2020 12:00 PM EDT hosted by Wayne Eskridge, our Co-Founder and CEO, along with Dr. Neeraj Mistry, our Chief Medical Officer, and a panel of leading clinicians and experts featuring Drs. Nadege Gunn, Brent Neuschwander-Tetri, and Scott Friedman who will review and discuss highlights from the EASL Digital Liver Conference 2020 and answer your questions.

 

To register for and participate in this free webinar, please visit www.fattyliverfoundation.org or email us at [email protected]. We look forward to your participation!

 

AGENDA*

12:00 pm – 12:10 pm

WELCOME AND INTRODUCTION

Host – Wayne Eskridge, Fatty Liver Foundation

Moderator – Neeraj Mistry, MD, MPH, Fatty Liver Foundation

12:10 pm – 12:30 pm

SESSION 1: LIFESTYLE AND DIET

New Data on Lifestyle and Dietary Interventions in NAFLD/NASH Management

Presenter – Nadege Gunn, MD, Texas A&M College of Medicine, Pinnacle Clinical Research, Austin Gastroenterology

Q&A – Neeraj Mistry, MD, MPH, Fatty Liver Foundation 

12:30 pm – 12:50 pm

SESSION 2: TESTING

Advances in Non-Invasive Biomarkers for Diagnosis and Monitoring of NAFLD/NASH

Presenter – Brent A. Neuschwander-Tetri, MD, NASH Studies Unit, Saint Louis University School of Medicine

Q&A – Moderator – Neeraj Mistry, MD, MPH, Fatty Liver Foundatoin

12:50 pm – 01:10 pm

SESSION 3: TREATMENT

Update on Investigational Drugs and Therapeutic Targets for NAFLD/NASH

Presenter – Scott L. Friedman, MD, Icahn School of Medicine at Mount Sinai

Q&A – Moderator – Neeraj Mistry, MD, MPH

01:10 pm – 01:15 pm

REFLECTIONS AND TAKEAWAY POINTS

Wayne Eskridge

 

*Subject to change. This educational program is supported by grants from Intercept Pharmaceuticals, Madrigal Pharmaceuticals, and NetNoggin. Fatty Liver Foundation maintains editorial control and independence over the educational program content.'

 

CLICK HERE to view the recording of LIVER 1


Click for our online community

connect